SCHEMBL10013899

SCHEMBL10013899

N=c1ccc2c(-c3ccccc3CO)c3ccc(N)cc3oc-2c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 1/20 0.62
USP2 O75604 5/20 0.60
ATM Q13315 2/20 0.60
CFTR P13569 1/20 0.60
PAX8 Q06710 1/20 0.60
GOPC Q9HD26 1/20 0.60
L3MBTL1 Q9Y468 2/20 0.40
MEN1 O00255 8/20 0.40
KMT2A Q03164 8/20 0.40
MAPT P10636 4/20 0.40
HPGD P15428 4/20 0.40
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 3/20 0.40
HDAC6 Q9UBN7 1/20 0.36
POLB P06746 3/20 0.36
PLEC Q15149 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
THRB P10828 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20256014 0.86 USP2 (0.55) ABCB1USP2ATMCFTRPAX8
SCHEMBL21648586 0.84 ABCB1 (0.66) ABCB1USP2ATMCFTRPAX8
SCHEMBL12827098 0.84 ABCB1 (0.63) ABCB1USP2ATMCFTRPAX8
SCHEMBL7907876 0.83 ABCB1 (0.71) ABCB1USP2ATMCFTRPAX8
SCHEMBL26774230 0.83 ABCB1 (0.52) ABCB1USP2ATMCFTRPAX8
SCHEMBL16425659 0.82 ABCB1 (0.63) ABCB1USP2ATMCFTRPAX8
SCHEMBL21648583 0.82 ABCB1 (0.63) ABCB1USP2ATMCFTRPAX8
SCHEMBL12747272 0.82 ABCB1 (0.66) ABCB1USP2ATMCFTRPAX8
SCHEMBL458205 0.81 ABCB1 (0.77) ABCB1USP2ATMCFTRPAX8
SCHEMBL4567588 0.80 ABCB1 (0.60) ABCB1USP2ATMCFTRPAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE49518-E1 Fluorescent probe for detecting calpain activity THE UNIVERSITY OF TOKYO (JP) 2023-05-02 US disclosed
US-RE49518-E1 Fluorescent probe for detecting calpain activity THE UNIVERSITY OF TOKYO (JP) 2023-05-02 US disclosed
WO-2022270607-A1 FLUORESCENT PROBES 株式会社 東北テクノアーチ 2022-12-29 WO disclosed
US-10294240-B2 Fluorescent probe for detecting calpain activity THE UNIVERSITY OF TOKYO (JP) 2019-05-21 US disclosed
US-20180162871-A1 FLUORESCENT PROBE FOR DETECTING CALPAIN ACTIVITY THE UNIVERSITY OF TOKYO (JP) 2018-06-14 US disclosed
US-9610366-B2 Method for diagnosing cancer THE UNIVERSITY OF TOKYO (JP) 2017-04-04 US disclosed
US-9610366-B2 Method for diagnosing cancer THE UNIVERSITY OF TOKYO (JP) 2017-04-04 US disclosed
US-9506102-B2 Fluorescent probe for high-sensitivity pancreatic fluid detection, and method for detecting pancreatic fluid THE UNIVERSITY OF TOKYO (JP) 2016-11-29 US disclosed
US-9506102-B2 Fluorescent probe for high-sensitivity pancreatic fluid detection, and method for detecting pancreatic fluid THE UNIVERSITY OF TOKYO (JP) 2016-11-29 US disclosed
EP-2399920-B1 FLUORESCENT PROBE FOR USE IN MEASUREMENT OF PROTEASE UNIV TOKYO (JP) 2015-03-25 EP disclosed
US-20140206992-A1 METHOD FOR DIAGNOSING CANCER THE UNIVERSITY OF TOKYO (JP) 2014-07-24 US disclosed
US-20140206992-A1 METHOD FOR DIAGNOSING CANCER THE UNIVERSITY OF TOKYO (JP) 2014-07-24 US disclosed
US-8461358-B2 Fluorescent probe for measuring protease THE UNIVERSITY OF TOKYO (JP) 2013-06-11 US disclosed
US-8461358-B2 Fluorescent probe for measuring protease THE UNIVERSITY OF TOKYO (JP) 2013-06-11 US disclosed
US-20130023675-A1 DIAGNOSTIC FOR CANCER THE UNIVERSITY OF TOKYO (JP) 2013-01-24 US disclosed
US-20130023675-A1 DIAGNOSTIC FOR CANCER THE UNIVERSITY OF TOKYO (JP) 2013-01-24 US disclosed
US-20120052518-A1 FLUORESCENT PROBE FOR MEASURING PROTEASE THE UNIVERSITY OF TOKYO (JP) 2012-03-01 US disclosed
EP-2399920-A1 FLUORESCENT PROBE FOR USE IN MEASUREMENT OF PROTEASE The University of Tokyo (JP) 2011-12-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180162871-A1 FLUORESCENT PROBE FOR DETECTING CALPAIN ACTIVITY CAPN1, CAPNS1, CAPN2 ABCB1 1972/4885USP2 1179/4885ATM 3862/4885
US-20130023675-A1 DIAGNOSTIC FOR CANCER CDC73, BRCA1, HNRNPH3 ABCB1 1208/4885USP2 2138/4885ATM 1655/4885
US-20140206992-A1 METHOD FOR DIAGNOSING CANCER H1-3, H1-10, C1R ABCB1 1447/4885USP2 1817/4885ATM 2217/4885
US-20120052518-A1 FLUORESCENT PROBE FOR MEASURING PROTEASE CTRL, PRSS3, PRSS1 ABCB1 2822/4885USP2 733/4885ATM 4637/4885
US-10294240-B2 Fluorescent probe for detecting calpain activity CAPN1, CAPNS1, CAPN2 ABCB1 1972/4885USP2 1179/4885ATM 3862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.